Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from CytoDyn ( (CYDY) ) is now available.
On February 27, 2026, CytoDyn disclosed that unregistered equity sales since January 9, 2026, had exceeded 5% of its outstanding common stock, driven largely by a private placement of roughly 81.4 million units of stock and warrants to accredited investors, raising about $17.5 million in cash at a unit price of $0.2153. The company also agreed to substantial cash and warrant compensation for its placement agent, executed additional direct sales of common stock and units totaling about $1.1 million in January and February 2026, drew roughly $0.2 million from a standby equity facility with Yorkville, and issued about 5.9 million shares in exchange for $1.5 million of convertible note principal, collectively strengthening liquidity while significantly expanding its share count and diluting existing holders.
On January 23, 2026, CytoDyn raised approximately $1.0 million in a direct private sale of nearly 3.9 million common shares without warrants, and on February 26, 2026, it accepted a further $100,000 investment on the same terms as the main placement. Earlier in January 2026, the company sold about 0.8 million shares for $0.2 million under its Standby Equity Purchase Agreement with Yorkville and, in January and February 2026, converted about $1.5 million of a convertible promissory note into roughly 5.9 million shares, reducing debt obligations while adding to equity dilution.
More about CytoDyn
CytoDyn operates in the biopharmaceutical sector, focusing on the development and commercialization of therapeutic products, with a capital strategy that relies heavily on equity financing through private placements, direct equity sales, and structured agreements with institutional investors to fund its ongoing operations and pipeline activities.
Average Trading Volume: 1,748,798
Technical Sentiment Signal: Sell
Current Market Cap: $293.6M
Learn more about CYDY stock on TipRanks’ Stock Analysis page.